After a first place finish Thursday night in the 50m breaststroke final, Lilly King was back in the pool Friday morning.

Is the market about to crash — or are we just getting started? Joseph Hogue breaks down three flashing red signals — from spiking margin debt to Fed policy risks — that could trigger a major ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

In honor of Higher Education Day, celebrate FIU’s earning its latest Carnegie recognition — and meet recent alumni who are ...

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...

Lilly Chiropractic improved to 4-0 in the Greater City League Thursday night, thanks to an 11-6 win over Imler’s Poultry at ...

The UK's MHRA have issued a warning to people on birth control who may also be taking drugs like Ozempic, Wegovy or Mounjaro ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

A powerful and wealthy church member left Christ Church, calling its leader "a hippie." Church women united around strawberry ...

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...